ALEVIATE human coagulation factor VIII 500IU / von Willebrand Factor 1200IU powder for injection vial with diluent vial

Valsts: Austrālija

Valoda: angļu

Klimata pārmaiņas: Department of Health (Therapeutic Goods Administration)

Aktīvā sastāvdaļa:

Von willebrand factor, Quantity: 1200 IU; Factor VIII, Quantity: 500 IU

Pieejams no:

CSL Behring Australia Pty Ltd

SNN (starptautisko nepatentēto nosaukumu):

Factor VIII,Von willebrand factor

Zāļu forma:

Injection, diluent for

Kompozīcija:

Excipient Ingredients:

Ievadīšanas:

Intravenous

Vienības iepakojumā:

Glass vial containing 500 IU FVIII, 1200 IU vWF supplied with 1 x 10 mL diluent vial

Receptes veids:

exempt from scheduling - Appendix A; prescription medicine

Ārstēšanas norādes:

The prophylaxis and treatment of non-surgical and surgical bleeding in patients with von Willebrand disease when desmopressin (DDAVP) treatment is ineffective or contraindicated. The prophylaxis and treatment of non-surgical and surgical bleeding associated with factor VIII deficiency due to haemophilia A.

Produktu pārskats:

Visual Identification: Clear and colourless; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 3 Years; Container Temperature: Store at 2 to 8 degrees Celsius

Autorizācija statuss:

Licence status A

Autorizācija datums:

2010-05-21